Financial reports
10-K
2023 FY
Annual report
1 Apr 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
23 May 22
NT 10-Q
Notice of late quarterly filing
17 May 22
10-K
2021 FY
Annual report
31 Mar 22
Current reports
8-K
Entry into a Material Definitive Agreement
3 Apr 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
26 Feb 24
8-K
Silexion, a Clinical-Stage, Oncology-Focused Biotechnology Company, to Become Publicly Traded Via Business Combination with Moringa Acquisition Corp
26 Feb 24
8-K
Entry into a Material Definitive Agreement
22 Aug 23
8-K
Moringa Acquisition Corp Announces Contribution to Trust Account In Connection with Proposed Extension
15 Aug 23
8-K
Termination of a Material Definitive Agreement
10 Aug 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
21 Jun 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
29 Mar 23
8-K
Entry into a Material Definitive Agreement
9 Feb 23
8-K
Moringa Acquisition Corp Announces Adjournment of Extraordinary
7 Feb 23
Registration and prospectus
425
Business combination disclosure
4 Jan 23
425
Business combination disclosure
6 Sep 22
425
Business combination disclosure
17 Aug 22
425
Business combination disclosure
13 Jun 22
424B4
Prospectus supplement with pricing info
17 Feb 21
8-A12B
Registration of securities on exchange
16 Feb 21
S-1/A
IPO registration (amended)
16 Feb 21
S-1
IPO registration
1 Feb 21
DRS
Draft registration statement
22 Dec 20
Proxies
DEFA14A
Additional proxy soliciting materials
16 Aug 23
DEFA14A
Additional proxy soliciting materials
15 Aug 23
DEFA14A
Additional proxy soliciting materials
10 Aug 23
DEF 14A
Definitive proxy
26 Jul 23
PRER14A
Preliminary revised proxy
25 Jul 23
PRER14A
Preliminary revised proxy
24 Jul 23
PRE 14A
Preliminary proxy
13 Jul 23
DEFA14A
Additional proxy soliciting materials
7 Feb 23
DEFA14A
Additional proxy soliciting materials
26 Jan 23
DEF 14A
Definitive proxy
5 Jan 23
Other
UPLOAD
Letter from SEC
26 Jul 23
CORRESP
Correspondence with SEC
24 Jul 23
UPLOAD
Letter from SEC
20 Jul 23
UPLOAD
Letter from SEC
23 Dec 22
CORRESP
Correspondence with SEC
22 Dec 22
UPLOAD
Letter from SEC
20 Dec 22
EFFECT
Notice of effectiveness
17 Feb 21
CERT
Certification of approval for exchange listing
16 Feb 21
CORRESP
Correspondence with SEC
16 Feb 21
CORRESP
Correspondence with SEC
16 Feb 21
Ownership
SC 13G/A
Radcliffe Capital Management, L.P.
14 Feb 24
SC 13G/A
ARISTEIA CAPITAL, L.L.C.
12 Feb 24
SC 13G/A
Saba Capital Management, L.P.
8 Feb 24
SC 13G
Yakira Capital Management, Inc.
26 Jan 24
SC 13G/A
GLAZER CAPITAL, LLC
11 Sep 23
4
Change in insider ownership
24 Aug 23
3
Sander Gerber
5 Apr 23
SC 13G/A
GLAZER CAPITAL, LLC
10 Mar 23
SC 13G
Radcliffe Capital Management, L.P.
16 Feb 23
SC 13G
GLAZER CAPITAL, LLC
14 Feb 23